CEFUROXIME-1500MGOther gastroenteritis and colitis of infectious and unspecified origin
How does the disease interact with Cifaxt 1.5Gm Inj:
Colitis: In some cases the use of Cifaxt 1.5Gm Inj may cause ranging from mild diarrhea to fatal colitis. Colitis is commonly Clostridioides difficile-associated diarrhea (CDAD). Discontinue therapy if signs of CDAD are confirmed.
How to manage the interaction:
Antibiotics may cause Clostridioides difficile-associated diarrhoea (CDAD), which may range from mild diarrhoea to fatal colitis. Cifaxt 1.5Gm Inj should be used with caution in patients with a history of gastrointestinal disease, particularly colitis (inflammation of the colon) or pseudomembranous colitis (a severe inflammation of the inner lining of the large intestine). Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C difficile, and surgical evaluation is advised.
CEFUROXIME-1500MGChronic kidney disease
How does the disease interact with Cifaxt 1.5Gm Inj:
Renal dysfunction:
Cifaxt 1.5Gm Inj is eliminated by the kidney in an unchanged form. Thus the plasma levels of the drug increase and prolongs the half-life. Adjust the doses of Cifaxt 1.5Gm Inj as necessary.
How to manage the interaction:
The serum concentration may be increased in patients with impaired kidney function as most beta-lactam antibiotics are eliminated by the kidney. Dose adjustment may be necessary for patients with kidney dysfunction. Regular renal function tests are advised during prolonged or high-dose therapy.
CEFUROXIME-1500MGDependence on enabling machines and devices, not elsewhere classified
How does the disease interact with Cifaxt 1.5Gm Inj:
Dialysis : Most of the antibiotics are eliminated by hemodialysis. Therefore, administer Cifaxt 1.5Gm Inj after dialysis or an additional dosage to be administered.
How to manage the interaction:
Cifaxt 1.5Gm Inj serum levels may be decreased by hemodialysis and peritoneal dialysis. Supplemental doses should be given at the end of each hemodialysis session.
CEFUROXIME-1500MGConvulsions, not elsewhere classified
How does the disease interact with Cifaxt 1.5Gm Inj:
seizure disorders:
In some patients, seizures were reported with whom renal dysfunction which incase of dosage adjustment was not done. Discontinue Cifaxt 1.5Gm Inj if seizures are reported.
How to manage the interaction:
Cephalosporin antibiotics may trigger seizures. Cifaxt 1.5Gm Inj should be discontinued if seizures associated with drug therapy occur.
CEFUROXIME-1500MGOther diseases of liver
How does the disease interact with Cifaxt 1.5Gm Inj:
liver disease: With Cifaxt 1.5Gm Inj, a transient increase in the AST, ALT, and alkaline phosphatase levels was observed. Use with caution and closely monitor for hepatic function is recommended.
How to manage the interaction:
Caution and monitoring is recommended in patients with liver disease as cases of hepatitis have been reported with the use of certain cephalosporins.
CEFUROXIME-1500MGOther diseases of liver
How does the disease interact with Cifaxt 1.5Gm Inj:
Rarely, cephalosporins use may cause hypoprothrombinemia, with or without bleeding. Monitor for Prothrombin time.
How to manage the interaction:
Cephalosporins may be associated with reduced prothrombin activity/prolonged prothrombin time (blood takes too long to form a clot). Prothrombin time should be monitored in at-risk patients and managed as needed.